Subject: [Announcement] Pharmaceuticals 2025 Travel Award – Deadline: 31 October 2024

IMPACT
FACTOR

4.3

Dear Colleagues,

We are pleased to announce that the application period is now open for the Pharmaceuticals 2025 Travel Award. The applications will be assessed by an Evaluation Committee chaired by the Section Editor-in-Chief of Pharmaceuticals.

This prize provides financial support for the winner to attend an international conference in the field of medicinal chemistry and related drug sciences to be held in 2025, in order to hold a presentation, present a poster, or both.

Requirements:

  • Postdoctoral fellows or PhD students.
  • Plans to attend an international conference in 2025 (oral presentation or poster).

Required Application Documents:

  • Information of the conference the applicant is planning to attend and the abstract that will be submitted.
  • Curriculum Vitae and list of publications.
  • Justification letter describing the focus of the research (max. 800 words).
  • Letter of recommendation from the supervisor, research director, or department head, which also confirms the applicant's status as a postdoctoral fellow/PhD student.

There will be one winner, who will be awarded CHF 800.

Please apply by clicking the link before 31 October 2024. The winner will be announced on 31 December 2024.

 

Kind regards,

Pharmaceuticals Editorial Office

 


Journal Information


Pharmaceuticals (ISSN 1424-8247) is an international scientific journal of medicinal chemistry and related drug sciences.

To submit to the journal click here.

Unsubscribe
Manage your subscriptions


MDPI
www.mdpi.com
St. Alban-Anlage 66, 4052 Basel, Switzerland

Tel. +41 61 683 77 34


Disclaimer: MDPI recognizes the importance of data privacy and protection. We treat personal data in line with the General Data Protection Regulation (GDPR) and with what the community expects of us. The information contained in this message is confidential and intended solely for the use of the individual or entity to whom they are addressed. If you have received this message in error, please notify me and delete this message from your system. You may not copy this message in its entirety or in part, or disclose its contents to anyone.


facebook twitter linkedin